GRCE vs KR · $35.0M cap vs P/E 19, rev $147.12B
Grace Therapeutics, Inc. (GRCE) versus Kroger Company (KR) — a side-by-side from cached financials, not a winner call.
Grace Therapeutics, Inc. (GRCE) is a biotechnology company listed on US.
Kroger Company (KR) is a grocery stores company listed on US.
GRCE does not have a complete income-statement cache yet.
Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
GRCE currently screens at market cap $35.0M. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Not investment advice. Open the GRCE and KR stock pages for the full models.
Not investment advice.